Role of obesity in the surgical management of advanced-stage ovarian cancer

J Reprod Med. 2004 Jun;49(6):473-6.

Abstract

Objective: To assess whether obese women with advanced-stage ovarian cancer undergoing primary cytoreduction surgery were at increased risk of suboptimal cytoreduction and complications during the operative and postoperative period as compared to nonobese women.

Study design: A retrospective, case-control study of all cases of advanced-stage epithelial ovarian cancer managed surgically at Johns Hopkins Hospital between January 1, 1990, and December 31, 1999.

Results: Obese patients were as likely as nonobese patients to undergo optimal cytoreduction at surgery. Obese patients were more likely than nonobese patients to be high-risk anesthesia candidates and more likely than nonobese patients to have tumors >20 cm at surgery. Obese patients were not at greater risk of surgical or postoperative complications than were nonobese patients.

Conclusion: Obesity is not a risk factor for suboptimal surgical management of advanced-stage ovarian cancer.

MeSH terms

  • Anesthesia, General / adverse effects
  • Anesthesia, General / methods
  • Case-Control Studies
  • Female
  • Gynecologic Surgical Procedures / adverse effects
  • Gynecologic Surgical Procedures / statistics & numerical data*
  • Humans
  • Middle Aged
  • Neoplasm Staging
  • Obesity / complications*
  • Ovarian Neoplasms / complications*
  • Ovarian Neoplasms / surgery*
  • Postoperative Complications*
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Retrospective Studies
  • Risk Factors